Applied Therapeutics (APLT) Retained Earnings (2023 - 2025)
Historic Retained Earnings for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to -$636.4 million.
- Applied Therapeutics' Retained Earnings fell 294.12% to -$636.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$636.4 million, marking a year-over-year decrease of 294.12%. This contributed to the annual value of -$574.2 million for FY2024, which is 2254.1% down from last year.
- As of Q3 2025, Applied Therapeutics' Retained Earnings stood at -$636.4 million, which was down 294.12% from -$617.4 million recorded in Q2 2025.
- Applied Therapeutics' 5-year Retained Earnings high stood at -$359.0 million for Q1 2023, and its period low was -$636.4 million during Q3 2025.
- Over the past 3 years, Applied Therapeutics' median Retained Earnings value was -$552.5 million (recorded in 2024), while the average stood at -$526.5 million.
- In the last 5 years, Applied Therapeutics' Retained Earnings plummeted by 5390.64% in 2024 and then tumbled by 294.12% in 2025.
- Over the past 3 years, Applied Therapeutics' Retained Earnings (Quarter) stood at -$468.6 million in 2023, then dropped by 22.54% to -$574.2 million in 2024, then fell by 10.83% to -$636.4 million in 2025.
- Its last three reported values are -$636.4 million in Q3 2025, -$617.4 million for Q2 2025, and -$596.0 million during Q1 2025.